Clinical and biochemical polymorphism of spinal muscular atrophy

Clinical and biochemical polymorphism of spinal muscular atrophy

Objective: to conduct clinical laboratory studies of spinal muscular atrophy (SMA) for the clarification of the pathogenetic features and role of neurotrophic factors in the formation of polymorphism of this diseasePatients and methods. Thirty-five patients aged 9 months to 53 years (mean age, 14.5...

Full description

Bibliographic Details
Main Authors: M. G. Sokolova, S. V. Lobzin, I. V. Litvinenko, M. V. Rezvantsev, L. A. Polyakova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2017-03-01
Series:Nevrologiâ, Nejropsihiatriâ, Psihosomatika
Subjects:
spinal muscular atrophy
polymorphism
neurotrophins
enzyme immunoassay
serum
Online Access:https://nnp.ima-press.net/nnp/article/view/697

Similar Items

Similar Items